BNY Mellon Global Equity Income Fund - Class C DEQCX

Medalist Rating as of | See BNY Mellon Investment Hub
  • NAV / 1-Day Return 15.98  /  +0.44 %
  • Total Assets 198.8M
  • Adj. Expense Ratio
    2.040%
  • Expense Ratio 2.040%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Global Large-Stock Value
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.63%
  • Turnover 54%

USD | NAV as of Oct 07, 2026 | 1-Day Return as of Oct 07, 2026, 12:11 AM GMT+0

Morningstar’s Analysis DEQCX

Will DEQCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BNY Mellon Global Equity Income - C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DEQCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 23.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

2.99 6M
Healthcare

CME Group Inc Class A

2.69 6M
Financial Services

AIA Group Ltd

2.50 5M
Financial Services

UnitedHealth Group Inc

2.33 5M
Healthcare

GSK PLC

2.25 5M
Healthcare

Texas Instruments Inc

2.23 5M
Technology

Smurfit WestRock PLC

2.22 5M
Consumer Cyclical

Elevance Health Inc

2.20 5M
Healthcare

Expand Energy Corp Ordinary Shares - New

2.16 5M
Energy

Barclays PLC

2.12 5M
Financial Services

Sponsor Center